This proposed rule focuses totally on PMTA review strategies and information requirements, specifically with regard to software acceptance and submitting. An software might fulfill the acceptance and filing prerequisites, but nonetheless deficiency essential information that FDA desires to ascertain whether or not it really should concern a promoti